Guardrails for the use of generalist AI in cancer care
Publikation: Beitrag in Fachzeitschrift › Kommentar (Comment) / Leserbriefe ohne eigene Daten › Beigetragen › Begutachtung
Beitragende
Abstract
Artificial narrow intelligence models, trained for specific intended purposes, have gained approval and recommendation for cancer treatment. Generalist medicial artificial intelligence (GMAI) models are now being developed for cancer treatment. Policy makers have a stark choice: radically adapt frameworks, block generalist approaches or force them onto narrower tracks.
Details
| Originalsprache | Englisch |
|---|---|
| Seiten (von - bis) | 357-358 |
| Seitenumfang | 2 |
| Fachzeitschrift | Nature Reviews Cancer |
| Jahrgang | 24 |
| Ausgabenummer | 6 |
| Frühes Online-Datum | 16 Apr. 2024 |
| Publikationsstatus | Veröffentlicht - Juni 2024 |
| Peer-Review-Status | Ja |
Externe IDs
| ORCID | /0000-0002-1997-1689/work/169175790 |
|---|